Gary Berman

Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial

John A. Smith, Michael M. Kitt, Alyn H. Morice et al. · The Lancet Respiratory Medicine · 2020 · 216 citations · Full text

Asthma, Pulmonary Care, Phase 2B +6

Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age

Evan J. Anderson, C. Buddy Creech, Vladimir Berthaud et al. · New England Journal of Medicine · 2022 · 136 citations · Full text

Randomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adults

Hendrik Nolte, Jacques Hébert, Gary Berman et al. · Annals of Allergy Asthma & Immunology · 2013 · 97 citations

Food Allergy, North American Adults, Allergy +9

Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine

Gary Berman, Robert Croop, David Kudrow et al. · Headache The Journal of Head and Face Pain · 2020 · 97 citations · Full text

An Otolaryngology, Neurology, Allergy, and Primary Care Consensus on Diagnosis and Treatment of Sinus Headache

Howard L. Levine, Michael Setzen, Roger Cady et al. · Otolaryngology · 2006 · 69 citations

Cluster Headache, Primary Care Consensus, Allergy +14